- Home
- AUPH vs OPEN Comparison
AUPH vs OPEN Comparison
Compare AUPH & OPEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- OPEN
- Stock Information
- Founded
- AUPH 1993
- OPEN 2014
- Country
- AUPH Canada
- OPEN United States
- Employees
- AUPH N/A
- OPEN N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- OPEN Real Estate
- Sector
- AUPH Health Care
- OPEN Finance
- Exchange
- AUPH Nasdaq
- OPEN Nasdaq
- Market Cap
- AUPH 1.4B
- OPEN 4.9B
- IPO Year
- AUPH 1999
- OPEN N/A
- Fundamental
- Price
- AUPH $12.30
- OPEN $10.21
- Analyst Decision
- AUPH Strong Buy
- OPEN Sell
- Analyst Count
- AUPH 3
- OPEN 4
- Target Price
- AUPH $12.00
- OPEN $1.45
- AVG Volume (30 Days)
- AUPH 1.5M
- OPEN 436.8M
- Earning Date
- AUPH 11-06-2025
- OPEN 11-06-2025
- Dividend Yield
- AUPH N/A
- OPEN N/A
- EPS Growth
- AUPH N/A
- OPEN N/A
- EPS
- AUPH 0.42
- OPEN N/A
- Revenue
- AUPH $260,111,000.00
- OPEN $5,181,000,000.00
- Revenue This Year
- AUPH $16.92
- OPEN N/A
- Revenue Next Year
- AUPH $14.43
- OPEN $1.19
- P/E Ratio
- AUPH $29.12
- OPEN N/A
- Revenue Growth
- AUPH 25.59
- OPEN 14.07
- 52 Week Low
- AUPH $6.55
- OPEN $0.51
- 52 Week High
- AUPH $12.90
- OPEN $10.87
- Technical
- Relative Strength Index (RSI)
- AUPH 56.77
- OPEN 71.93
- Support Level
- AUPH $12.06
- OPEN $5.57
- Resistance Level
- AUPH $12.90
- OPEN $10.50
- Average True Range (ATR)
- AUPH 0.39
- OPEN 1.19
- MACD
- AUPH -0.08
- OPEN 0.38
- Stochastic Oscillator
- AUPH 54.89
- OPEN 90.28
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About OPEN Opendoor Technologies Inc
Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.